Logo-bma
Biomed adv. 2026;3(2): 44-46. doi: 10.34172/bma.68

Opinion

Mitochondrial-derived vesicles: Rethinking a quality control pathway as a therapeutic opportunity

Fatima Elmusa 1 ORCID, Mohammadreza Dastouri 2 * ORCID

Cited by CrossRef:


1- Mirzohreh S, Ghaffari S, Mesri Alamdari N, Banisefid E, Ghaffari M, Shabestari A, Imanzadeh Ghazijahani A, Roshanravan N, Tarighat F, Datta Choudhury S. Nutraceuticals for Preventing and Managing Cancer Chemotherapy–Induced Cardiotoxicity: An Updated Comprehensive Review. Cardiology Research and Practice. 2026;2026(1) [Crossref]

Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

In collaboration with